Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Infectious Disease
•
Infection Prevention and Control
What testing strategy should be used to identify when to stop transmission-based precautions for hospitalized, immunocompetent patients with COVID-19 infection?
Related Questions
What is the current evidence for ending isolation protocols for moderately or severely immunocompromised patients with COVID-19 infection?
In patients taking biologics who are planning joint replacement and are known MRSA carriers do you perform decolonization prior to surgery?
Are contact precautions effective at preventing MRSA transmission in healthcare settings?
Are contact precautions effective at preventing transmission of COVID-19 infection in healthcare settings?
When do you discontinue contact precautions in patients known to be colonized with ESBL producing Enterobacterales?
What isolation policies are Rheumatology offices employing for both staff and patients diagnosed with COVID-19 given the new CDC guidelines?
In drawing blood cultures from a central line to evaluate for CLABSI, do you advise drawing separate blood cultures from each port in case of dual or triple lumen line?
What is your approach to secondary prophylaxis for C difficile infection during concomitant antibiotic use in a patient with a history of C difficile infection?
Should checking a urinalysis with reflex to culture be part of the standard work up for fever in an ICU patient with a urinary catheter?
What is the risk of serious bacterial infection in a febrile solid tumor patient who has not yet started cancer-directed therapy and has normal cell counts with no central line?
